Navigation Links
Toxicology program features wide range of human health and environment topical sessions

Reston, VA (February 19, 2009) - Nearly 6,500 toxicologists from around the world will be gathering in Baltimore, Maryland March 15-19, to create an unparalleled venue for discussion of a number of health and environmental topics of concern to the public. The Society of Toxicology's 2009 Annual Meeting and ToxExpo brings together thousands of scientists from universities, government, and industry to showcase a year's worth of achievements in research and education. Some of the topics that will be covered include the following:

The National Children's Study

The first of its kind in the U.S., this study has been designed to track children's health from womb to adulthood. The study will involve 100,000 children from across the country and is the largest long-term study of children's health and development ever conducted in the United States. The study's hypotheses incorporate the following main outcomespregnancy outcomes, neurodevelopment and behavior, asthma, obesity and growth, injury and reproductive development. At this roundtable session, toxicologists and others involved in this study will explore the study design and begin to examine the data that can be gathered so that questions like the following can be addressed: Can very early exposure to some allergens actually help children remain asthma-free? How do genes and the environment interact to promote or prevent violent behavior in teens? Are lack of exercise and poor diet the only reasons why many children are overweight? Do infections impact developmental progress, asthma, obesity and heart disease?

Biomarkers: New Breakthroughs in the World of Air Pollution Studies

Biomarker measurement allows scientists to better understand the factors that influence the health outcomes from air pollutant exposures. Toxicologists will examine new biomarker strategies and how they can be used to study health affects that come from air pollution. Panelists will explore improved use of biomarkers of exposure, effects and susceptibility. For example, one panelist will explore the optimal urinary biomarkers to use in order to examine the dose of combustion products and paving materials. Another panelist will highlight a variety of diseases and then equate these to particulate levels.

MicroRNAs in Biology and Toxicology

The field of microRNAs is relatively new and offers much promise in helping scientists understand mechanisms of toxicity. For example, recent studies have shown that microRNAs have important roles during embryonic development and disruption of microRNA synthesis in embryos can have dramatic consequences. MicroRNAs also are involved in several human studies and appear to regulate cellular responses to a variety of physiological and environmental stressors including diabetes, high blood pressure, nutrient stress hypoxia, and environmental chemicals.

Food Allergy: Basic Mechanisms and Applications to Identifying Risks Associated with Plant Incorporated Pesticides and Other Genetically Modified Crops

Food allergy is a relatively new concern for toxicologists as a result of the incorporation of novel proteins into food crops as a way of promoting resistance to pest and other stresses, improve nutrition or otherwise modify the crop. There is growing concern that the introduction of a novel protein into the food supply could result in the unintentional introduction of a new food allergen and could pose a risk to susceptible individuals. Toxicologists will explore this issue and talk about a number of strategies that have been used to help scientists develop improved hazard identification methods.

The 48th Annual Meeting also features more than 2,000 abstracts that will be presented in poster and platform sessions on a wide array of topics. The event also features 27 symposia, 19 workshops and 14 roundtable discussions, with sessions addressing such topics as neurodegenerative disease, engineered nanomaterials, inflammation, preclinical evaluation of cancer hazard and biopharmaceuticals and two lectures by Nobel laureates Dr. Aaron Ciechanover who will lecture on cellular mechanisms of protein degradation and Dr. Paul Greengard who will lecture on cellular signaling pathways.


Contact: Martha Lindauer
Oxford University Press

Related biology news :

1. Donation for new Center for Pharmaceutical Nanotechnology and Nanotoxicology
2. Scientists form alliance to develop nanotoxicology protocols
3. Biophysical sciences program receives $2 million training grant
4. UTSA wins $500,000 to develop biosensor and regenerative medicine Ph.D. program
5. Mycotoxin Research joins Springers life sciences journals program
6. Merck and AAAS announce 2009 winners of outstanding undergraduate research programs
7. WCC Smart Search & Match to Support U.S. Armys BOSS-U Program
8. Genomatix joins Illumina-Connect program
9. Nutritional supplementation program helps prevent weight loss among children in African country
10. CACI Awarded a Prime Position on $500 Million, Multiple-Award Program with Biometrics Operations and Support Services
11. New research program for energy innovations
Post Your Comments:
(Date:8/23/2017)... help is being enlisted in what,s thought to be the biggest study ... body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest study to date of ... goal is to help advance scientific knowledge of the role of these ... The Microbiome ...
(Date:6/23/2017)... and ITHACA, N.Y. , June 23, ... University, a leader in dairy research, today announced a ... to help reduce the chances that the global milk ... of this dairy project, Cornell University has become the ... the Food Supply Chain, a food safety initiative that ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life ... for the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan ... The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary ...
Breaking Biology Technology: